Inhibitors of lipoprotein-associated phospholipase A2

被引：0
|
作者：
Barrett, D
Barlocco, D
机构：
[1] Fujisawa Pharmaceut Co Ltd, Yodogawa Ku, Osaka 5328514, Japan
[2] Univ Milan, I-20131 Milan, Italy
来源：
DRUG DISCOVERY TODAY | 2001年 / 6卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：269 / 270
页数：2
相关论文
共 50 条
  • [1] Lipoprotein-associated phospholipase A2 inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (07) : 301 - 301
  • [2] Recent Developments with Lipoprotein-Associated Phospholipase A2 Inhibitors
    Ryan J. Chauffe
    Robert L. Wilensky
    Emile R. Mohler
    Current Atherosclerosis Reports, 2010, 12 : 43 - 47
  • [3] Recent Developments with Lipoprotein-Associated Phospholipase A2 Inhibitors
    Chauffe, Ryan J.
    Wilensky, Robert L.
    Mohler, Emile R., III
    CURRENT ATHEROSCLEROSIS REPORTS, 2010, 12 (01) : 43 - 47
  • [4] Lipoprotein-associated phospholipase A2
    McConnell, Joseph P.
    Hoefner, Daniel M.
    CLINICS IN LABORATORY MEDICINE, 2006, 26 (03) : 679 - +
  • [5] Lipoprotein-associated phospholipase A2 and atherosclerosis
    Wilensky, Robert L.
    Macphee, Colin H.
    CURRENT OPINION IN LIPIDOLOGY, 2009, 20 (05) : 415 - 420
  • [6] LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 AND STROKE
    Alvarez-Perez, F. J.
    Verde, I.
    REVISTA DE NEUROLOGIA, 2009, 49 (02) : 88 - 94
  • [7] Selective inhibitors and tailored activity probes for lipoprotein-associated phospholipase A2
    Nagano, Joseph M. G.
    Hsu, Ku-Lung
    Whitby, Landon R.
    Niphakis, Micah J.
    Speers, Anna E.
    Brown, Steven J.
    Spicer, Timothy
    Fernandez-Vega, Virneliz
    Ferguson, Jill
    Hodder, Peter
    Srinivasan, Prabhavathi
    Gonzalez, Tara D.
    Rosen, Hugh
    Bahnson, Brian J.
    Cravatt, Benjamin F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (03) : 839 - 843
  • [8] Lipoprotein-associated phospholipase A2 and risk of stroke
    Gorelick, Philip B.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (12A): : 34F - 40F
  • [9] Role of Lipoprotein-Associated Phospholipase A2 in Atherosclerosis
    Lavi, Shahar
    Herrmann, Joerg
    Lavi, Ronit
    McConnell, Joseph P.
    Lerman, Lilach O.
    Lerman, Amir
    CURRENT ATHEROSCLEROSIS REPORTS, 2008, 10 (03) : 230 - 235
  • [10] Clinical Role of Lipoprotein-Associated Phospholipase A2
    Miklishanskaya, S. V.
    Lyakishev, A. A.
    Kukharchuk, V. V.
    KARDIOLOGIYA, 2013, 53 (03) : 59 - 70
12345